Improvement mouse beta-thalassemia recombinant human erythropoietin Homozygous beta thalassemic mice U/kg recombinant human erythropoietin rhEpo days week weeks Hemoglobin g/dL g/dL beta minor/alpha globin chain synthesis ratio day day minimum ratio day parallel counts trichloracetic acid TCA -insoluble radioactivity parallel erythropoietic output thalassemic mice normal mice Erythrocyte defects beta thalassemic mice rhEpo membrane-associated alpha globin thiol group reactivity ankyrin spectrin alterations deformability mouse thalassemic red blood cells results experimental criteria globin chain imbalance necessary therapy human beta thalassemia intermedia rhEpo interest red blood cell mass erythrocyte alterations disease 